Curcumin attenuates vascular inflammation and cerebral vasospasm after subarachnoid hemorrhage in mice

Antioxidants and Redox Signaling

Volumn 11, Issue 1, 2009, Pages 35-45

  Wakade, Chandramohan ^a   King, Melanie D ^a   Laird, Melissa D ^a   Alleyne Jr , Cargill H ^a   Dhandapani, Krishnan M ^a  

^a MEDICAL COLLEGE OF GEORGIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CURCUMIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN ARTERY; BRAIN CORTEX; BRAIN INFARCTION; BRAIN INJURY; BRAIN PROTECTION; BRAIN VASOSPASM; CONTROLLED STUDY; DISEASE COURSE; DRUG EFFECT; GENE EXPRESSION; INFLAMMATION; LIPID PEROXIDATION; MALE; MOUSE; NONHUMAN; OXIDATIVE STRESS; PATHOGENESIS; PRIORITY JOURNAL; SUBARACHNOID HEMORRHAGE; TREATMENT OUTCOME; VASCULAR DISEASE;

ANIMALS; CURCUMIN; DISEASE MODELS, ANIMAL; ENDOTHELIUM, VASCULAR; INFLAMMATION; LIPID PEROXIDATION; MALE; MICE; MICE, INBRED STRAINS; NF-KAPPA B; SUBARACHNOID HEMORRHAGE; SUPEROXIDES; THIOBARBITURIC ACID REACTIVE SUBSTANCES; VASOSPASM, INTRACRANIAL;

MUS;

EID: 55249104098     PISSN: 15230864     EISSN: None     Source Type: Journal    
DOI: 10.1089/ars.2008.2056     Document Type: Article

References (66)

1. Ammon HP and Wahl MA. Pharmacology of Curcuma longa. Planta Med 57: 1-7, 1991.
2. Asano T and Matsui T. Antioxidant therapy against cerebral vasospasm following aneurysmal subarachnoid hemorrhage. Cell Mol Neurobiol 19: 31-44, 1999.
3. Ayer RE and Zhang JH. Oxidative stress in subarachnoid haemorrhage: significance in acute brain injury and vasospasm. Acta Neurochir Suppl 104: 33-41, 2008.
4. Bederson JB, Levy AL, Ding WH, Kahn R, DiPerna CA, Jenkins AL 3rd, and Vallabhajosyula P. Acute vasoconstriction after subarachnoid hemorrhage. Neurosurgery 42: 352-360; discussion 360-352, 1998.
5. Brann DW, Dhandapani K, Wakade C, Mahesh VB, and Khan MM. Neurotrophic and neuroprotective actions of estrogen: basic mechanisms and clinical implications. Steroids 72: 381-405, 2007.
6. Brilstra EH, Rinkel GJ, Algra A, and van Gijn J. Rebleeding, secondary ischemia, and timing of operation in patients with subarachnoid hemorrhage. Neurology 55: 1656-1660, 2000.
7. Cahill J, Calvert JW, and Zhang JH. Mechanisms of early brain injury after subarachnoid hemorrhage. J Cereb Blood Flow Metab 26: 1341-1353, 2006.
8. Cheng AL, Hsu CH, Lin JK, Hsu MM, Ho YF, Shen TS, Ko JY, Lin JT, Lin BR, Ming-Shiang W, Yu HS, Jee SH, Chen GS, Chen TM, Chen CA, Lai MK, Pu YS, Pan MH, Wang YJ, Tsai CC, and Hsieh CY. Phase I clinical trial of curcumin, a chemopreventive agent, in patients with high-risk or pre-malignant lesions. Anticancer Res 21: 2895-2900, 2001.
9. Cole GM, Teter B, and Frautschy SA. Neuroprotective effects of curcumin. Adv Exp Med Biol 595: 197-212, 2007.
10. Costantini LC, Bakowska JC, Breakefield XO, and Isacson O. Gene therapy in the CNS. Gene Ther 7: 93-109, 2000.
11. Cui Z, Wang H, Tan Y, Zaia KA, Zhang S, and Tsien JZ. Inducible and reversible NR1 knockout reveals crucial role of the NMDA receptor in preserving remote memories in the brain. Neuron 41: 781-793, 2004.
12. Dal-Pizzol F, Klamt F, Vianna MM, Schroder N, Quevedo J, Benfato MS, Moreira JC, and Walz R. Lipid peroxidation in hippocampus early and late after status epilepticus induced by pilocarpine or kainic acid in Wistar rats. Neurosci Lett 291: 179-182, 2000.
13. Deby-Dupont G, Mouithys-Mickalad A, Serteyn D, Lamy M, and Deby C. Resveratrol and curcumin reduce the respiratory burst of Chlamydia-primed THP-1 cells. Biochem Biophys Res Commun 333: 21-27, 2005.
14. Dhandapani KM, Khan MM, Wade FM, Wakade C, Mahesh VB, and Brann DW. Induction of transforming growth factor-beta1 by basic fibroblast growth factor in rat C6 glioma cells and astrocytes is mediated by MEK/ERK signaling and AP-1 activation. J Neurosci Res 85: 1033-1045, 2007.
15. Dhandapani KM, Mahesh VB, and Brann DW. Curcumin suppresses growth and chemoresistance of human glioblastoma cells via AP-1 and NFkappaB transcription factors. J Neurochem 102: 522-538, 2007.
16. Dhandapani KM, Wade FM, Wakade C, Mahesh VB, and Brann DW. Neuroprotection by stem cell factor in rat cortical neurons involves AKT and NFkappaB. J Neurochem 95: 9-19, 2005.
17. Dreier JP, Woitzik J, Fabricius M, Bhatia R, Major S, Drenckhahn C, Lehmann TN, Sarrafzadeh A, Willumsen L, Hartings JA, Sakowitz OW, Seemann JH, Thieme A, Lauritzen M, and Strong AJ. Delayed ischaemic neurological deficits after subarachnoid haemorrhage are associated with clusters of spreading depolarizations. Brain 129: 3224-3237, 2006.
18. Dumont AS, Dumont RJ, Chow MM, Lin CL, Calisaneller T, Ley KF, Kassell NF, and Lee KS. Cerebral vasospasm after subarachnoid hemorrhage: putative role of inflammation. Neurosurgery 53: 123-133; discussion 133-125, 2003.
19. Feigin VL, Lawes CM, Bennett DA, and Anderson CS. Stroke epidemiology: a review of population-based studies of incidence, prevalence, and case-fatality in the late 20th century. Lancet Neurol 2: 43-53, 2003.
20. Fergusen S and Macdonald RL. Predictors of cerebral infarction in patients with aneurysmal subarachnoid hemorrhage. Neurosurgery 60: 658-667; discussion 667, 2007.
21. Gaetani P, Pasqualin A, Rodriguez y Baena R, Borasio E, and Marzatico F. Oxidative stress in the human brain after subarachnoid hemorrhage. J Neurosurg 89: 748-754, 1998.
22. Garodia P, Ichikawa H, Malani N, Sethi G, and Aggarwal BB. From ancient medicine to modern medicine: Ayurvedic concepts of health and their role in inflammation and cancer. J Soc Integr Oncol 5: 25-37, 2007.
23. Hadjivassiliou M, Tooth CL, Romanowski CA, Byrne J, Battersby RD, Oxbury S, Crewswell CS, Burkitt E, Stokes NA, Paul C, Mayes AR, and Sagar HJ. Aneurysmal SAH: cognitive outcome and structural damage after clipping or coiling. Neurology 56: 1672-1677, 2001.
24. Hansen-Schwartz J, Vajkoczy P, Macdonald RL, Pluta RM, and Zhang JH. Cerebral vasospasm: looking beyond vasoconstriction. Trends Pharmacol Sci 28: 252-256, 2007.
25. Hendryk S, Jarzab B, and Josko J. Increase of the IL-1 beta and IL-6 levels in CSF in patients with vasospasm following aneurysmal SAH. Neurol Endocrinol Lett 25: 141-147, 2004.
26. Holder GM, Plummer JL, and Ryan AJ. The metabolism and excretion of curcumin (1,7-bis-(4-hydroxy-3-methoxyphenyl)-1,6-heptadiene-3,5-dione) in the rat. Xenobiotica 8: 761-768, 1978.
27. Jiang J, Wang W, Sun YJ, Hu M, Li F, and Zhu DY. Neuroprotective effect of curcumin on focal cerebral ischemic rats by preventing blood-brain barrier damage. Eur J Pharmacol 561: 54-62, 2007.
28. Karin M and Delhase M. The I kappa B kinase (IKK) and NF-kappa B: key elements of proinflammatory signalling. Semin Immunol 12: 85-98, 2000.
29. Kim DE, Suh YS, Lee MS, Kim KY, Lee JH, Lee HS, Hong KW, and Kim CD. Vascular NAD(P)H oxidase triggers delayed cerebral vasospasm after subarachnoid hemorrhage in rats. Stroke 33: 2687-2691, 2002.
30. Lim GP, Chu T, Yang F, Beech W, Frautschy SA, and Cole GM. The curry spice curcumin reduces oxidative damage and amyloid pathology in an Alzheimer transgenic mouse. J Neurosci 21: 8370-8377, 2001.
31. Lin CL, Hsu YT, Lin TK, Morrow JD, Hsu JC, Hsu YH, Hsieh TC, Tsay PK, and Yen HC. Increased levels of F2-isoprostanes following aneurysmal subarachnoid hemorrhage in humans. Free Radic Biol Med 40: 1466-1473, 2006.
32. Macdonald RL, Weir BK, Runzer TD, Grace MG, and Poznansky MJ. Effect of intrathecal superoxide dismutase and catalase on oxyhemoglobin-induced vasospasm in monkeys. Neurosurgery 30: 529-539, 1992.
33. McGirt MJ, Lynch JR, Parra A, Sheng H, Pearlstein RD, Laskowitz DT, Pelligrino DA, and Warner DS. Simvastatin increases endothelial nitric oxide synthase and ameliorates cerebral vasospasm resulting from subarachnoid hemorrhage. Stroke 33: 2950-2956, 2002.
34. McGirt MJ, Parra A, Sheng H, Higuchi Y, Oury TD, Laskowitz DT, Pearlstein RD, and Warner DS. Attenuation of cerebral vasospasm after subarachnoid hemorrhage in mice overexpressing extracellular superoxide dismutase. Stroke 33: 2317-2323, 2002.
35. Medele RJ, Stummer W, Reulen HJ, and Steiger HJ. Evidence for peroxidative damage by nitric oxide in experimental chronic cerebral vasospasm. Neurol Res 18: 277-280, 1996.
36. Mehta SH, Dhandapani KM, De Sevilla LM, Webb RC, Mahesh VB, and Brann DW. Tamoxifen, a selective estrogen receptor modulator, reduces ischemic damage caused by middle cerebral artery occlusion in the ovariectomized female rat. Neuroendocrinology 77: 44-50, 2003.
37. Menon VP and Sudheer AR. Antioxidant and anti-inflammatory properties of curcumin. Adv Exp Med Biol 595: 105-125, 2007.
38. Mesis RG, Wang H, Lombard FW, Yates R, Vitek MP, Borel CO, Warner DS, and Laskowitz DT. Dissociation between vasospasm and functional improvement in a murine model of subarachnoid hemorrhage. Neurosurg Focus 21: E4, 2006.
39. Meyer CH, Lowe D, Meyer M, Richardson PL, and Neil-Dwyer G. Progressive change in cerebral blood flow during the first three weeks after subarachnoid hemorrhage. Neurosurgery 12: 58-76, 1983.
40. Mishra B, Priyadarsini KI, Bhide MK, Kadam RM, and Mohan H. Reactions of superoxide radicals with curcumin: probable mechanisms by optical spectroscopy and EPR. Free Radic Res 38: 355-362, 2004.
41. Mori T, Nagata K, Town T, Tan J, Matsui T, and Asano T. Intracisternal increase of superoxide anion production in a canine subarachnoid hemorrhage model. Stroke 32: 636-642, 2001.
42. Ohkuma H, Manabe H, Tanaka M, and Suzuki S. Impact of cerebral microcirculatory changes on cerebral blood flow during cerebral vasospasm after aneurysmal subarachnoid hemorrhage. Stroke 31: 1621-1627, 2000.
43. Osaka K. Prolonged vasospasm produced by the breakdown products of erythrocytes. J Neurosurg 47: 403-411, 1977.
44. Ostrowski RP, Colohan AR, and Zhang JH. Molecular mechanisms of early brain injury after subarachnoid hemorrhage. Neurol Res 28: 399-414, 2006.
45. Pan MH, Huang TM, and Lin JK. Biotransformation of curcumin through reduction and glucuronidation in mice. Drug Metab Dispos 27: 486-494, 1999.
46. Park S, Yamaguchi M, Zhou C, Calvert JW, Tang J, and Zhang JH. Neurovascular protection reduces early brain injury after subarachnoid hemorrhage. Stroke 35: 2412-2417, 2004.
47. Parra A, McGirt MJ, Sheng H, Laskowitz DT, Pearlstein RD, and Warner DS. Mouse model of subarachnoid hemorrhage associated cerebral vasospasm: methodological analysis. Neurol Res 24: 510-516, 2002.
48. Provencio JJ and Vora N. Subarachnoid hemorrhage and inflammation: bench to bedside and back. Semin Neurol 25: 435-444, 2005.
49. Rabinstein AA, Weigand S, Atkinson JL, and Wijdicks EF. Patterns of cerebral infarction in aneurysmal subarachnoid hemorrhage. Stroke 36: 992-997, 2005.
50. Ravindranath V and Chandrasekhara N. Absorption and tissue distribution of curcumin in rats. Toxicology 16: 259-265, 1980.
51. Reddy AC and Lokesh BR. Studies on spice principles as antioxidants in the inhibition of lipid peroxidation of rat liver microsomes. Mol Cell Biochem 111: 117-124, 1992.
52. Rothoerl RD, Schebesch KM, Kubitza M, Woertgen C, Brawanski A, and Pina AL. ICAM-1 and VCAM-1 expression following aneurysmal subarachnoid hemorrhage and their possible role in the pathophysiology of subsequent ischemic deficits. Cerebrovasc Dis 22: 143-149, 2006.
53. Sayama T, Suzuki S, and Fukui M. Role of inducible nitric oxide synthase in the cerebral vasospasm after subarachnoid hemorrhage in rats. Neurol Res 21: 293-298, 1999.
54. Shimoda M, Takeuchi M, Tominaga J, Oda S, Kumasaka A, and Tsugane R. Asymptomatic versus symptomatic infarcts from vasospasm in patients with subarachnoid hemorrhage: serial magnetic resonance imaging. Neurosurgery 49: 1341-1348; discussion 1348-1350, 2001.
55. Shishodia S, Sethi G, and Aggarwal BB. Curcumin: getting back to the roots. Ann N Y Acad Sci 1056: 206-217, 2005.
56. Sreejayan and Rao MN. Curcuminoids as potent inhibitors of lipid peroxidation. J Pharm Pharmacol 46: 1013-1016, 1994.
57. Subramanian M, Sreejayan, Rao MN, Devasagayam TP, and Singh BB. Diminution of singlet oxygen-induced DNA damage by curcumin and related antioxidants. Mutat Res 311: 249-255, 1994.
58. Takeuchi K, Renic M, Bohman QC, Harder DR, Miyata N, and Roman RJ. Reversal of delayed vasospasm by an inhibitor of the synthesis of 20-HETE. Am J Physiol Heart Circ Physiol 289: H2203-H2211, 2005.
59. Takuwa Y, Matsui T, Abe Y, Nagafuji T, Yamashita K, and Asano T. Alterations in protein kinase C activity and membrane lipid metabolism in cerebral vasospasm after subarachnoid hemorrhage. J Cereb Blood Flow Metab 13: 409-415, 1993.
60. Thiyagarajan M and Sharma SS. Neuroprotective effect of curcumin in middle cerebral artery occlusion induced focal cerebral ischemia in rats. Life Sci 74: 969-985, 2004.
61. Unnikrishnan MK and Rao MN. Curcumin inhibits nitrite-induced methemoglobin formation. FEBS Lett 301: 195-196, 1992.
62. Vajkoczy P, Meyer B, Weidauer S, Raabe A, Thome C, Ringel F, Breu V, and Schmiedek P. Clazosentan (AXV-034343), a selective endothelin A receptor antagonist, in the prevention of cerebral vasospasm following severe aneurysmal subarachnoid hemorrhage: results of a randomized, double-blind, placebo-controlled, multicenter phase IIa study. J Neurosurg 103: 9-17, 2005.
63. Widenka DC, Medele RJ, Stummer W, Bise K, and Steiger HJ. Inducible nitric oxide synthase: a possible key factor in the pathogenesis of chronic vasospasm after experimental subarachnoid hemorrhage. J Neurosurg 90: 1098-1104, 1999.
64. Wong LF, Goodhead L, Prat C, Mitrophanous KA, Kingsman SM, and Mazarakis ND. Lentivirus-mediated gene transfer to the central nervous system: therapeutic and research applications. Hum Gene Ther 17: 1-9, 2006.
65. Zheng JS, Zhan RY, Zheng SS, Zhou YQ, Tong Y, and Wan S. Inhibition of NADPH oxidase attenuates vasospasm after experimental subarachnoid hemorrhage in rats. Stroke 36: 1059-1064, 2005.
66. Zhou ML, Shi JX, Hang CH, Cheng HL, Qi XP, Mao L, Chen KF, and Yin HX. Potential contribution of nuclear factor-kappaB to cerebral vasospasm after experimental subarachnoid hemorrhage in rabbits. J Cereb Blood Flow Metab 27: 1583-1592, 2007.